Clinical Pharmacy Congress 2022

IF 1.3 Q4 NEUROSCIENCES

Progress in Neurology and Psychiatry Pub Date : 2023-01-01 DOI:10.1002/pnp.781

引用次数: 0

Abstract

The Clinical Pharmacy Congress 2022 marked its 11th birthday, celebrating the return to normality after the pandemic with the delivery of over 250 educational sessions by industry experts over two days, to enhance the professional and personal development of attendees. Joy Ogden covers some highlights of the conference on thought‐provoking subjects such as risks of dementia with antimuscarinics and sessions on clinical priorities in epilepsy and headache.

查看原文本刊更多论文

2022年临床药学大会

2022年临床药学大会迎来了11岁生日，庆祝疫情后恢复正常，行业专家在两天内举办了250多场教育会议，以加强与会者的专业和个人发展。Joy Ogden介绍了会议上一些发人深省的主题，如抗毒药物对痴呆的风险，以及癫痫和头痛的临床重点会议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Progress in Neurology and Psychiatry NEUROSCIENCES-

CiteScore

1.70

自引率

8.30%

发文量

期刊介绍： Progress in Neurology and Psychiatry is published nine times a year, and is a journal for specialists in secondary care, GPs with an interest in neurology and psychiatry, community psychiatric nurses and other specialist healthcare professionals. Articles cover management, news updates and opinion in all areas of neurology and psychiatry.